These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
608 related items for PubMed ID: 12186805
21. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ. Can J Physiol Pharmacol; 2006 Feb; 84(2):163-71. PubMed ID: 16900942 [Abstract] [Full Text] [Related]
22. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons. Selley ML. J Neurosci Res; 2004 Jul 01; 77(1):90-3. PubMed ID: 15197741 [Abstract] [Full Text] [Related]
23. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Deng S, Deng PY, Jiang JL, Ye F, Yu J, Yang TL, Deng HD, Li YJ. Acta Pharmacol Sin; 2004 Dec 01; 25(12):1633-9. PubMed ID: 15569408 [Abstract] [Full Text] [Related]
24. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. Selley ML. J Affect Disord; 2004 Jun 01; 80(2-3):249-56. PubMed ID: 15207938 [Abstract] [Full Text] [Related]
25. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes. Xiong Y, Lei M, Fu S, Fu Y. Life Sci; 2005 May 27; 77(2):149-59. PubMed ID: 15862600 [Abstract] [Full Text] [Related]
26. The association of adipose-derived dimethylarginine dimethylaminohydrolase-2 with insulin sensitivity in experimental type 2 diabetes mellitus. Zheng J, Wang K, Jin P, Dong C, Yuan Q, Li Y, Yang Z. Acta Biochim Biophys Sin (Shanghai); 2013 Aug 27; 45(8):641-8. PubMed ID: 23702602 [Abstract] [Full Text] [Related]
27. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M, Liu L, Guo Z, Xiong Y. Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305 [Abstract] [Full Text] [Related]
28. Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. El Assar M, Angulo J, Santos-Ruiz M, Ruiz de Adana JC, Pindado ML, Sánchez-Ferrer A, Hernández A, Rodríguez-Mañas L. J Physiol; 2016 Jun 01; 594(11):3045-60. PubMed ID: 26840628 [Abstract] [Full Text] [Related]
29. Association of asymmetric dimethylarginine and endothelial dysfunction. Böger RH. Clin Chem Lab Med; 2003 Nov 01; 41(11):1467-72. PubMed ID: 14656027 [Abstract] [Full Text] [Related]
30. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ. Acta Pharmacol Sin; 2004 Jul 01; 25(7):893-901. PubMed ID: 15210062 [Abstract] [Full Text] [Related]
31. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction. McCarty MF. Med Hypotheses; 2004 Jul 01; 63(4):699-708. PubMed ID: 15325021 [Abstract] [Full Text] [Related]
32. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits. Lin Y, Feng M, Lu CW, Lei YP, He ZM, Xiong Y. Eur J Pharmacol; 2017 Mar 05; 798():43-48. PubMed ID: 28163022 [Abstract] [Full Text] [Related]
33. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis. Segarra G, Cortina B, Mauricio MD, Novella S, Lluch P, Navarrete-Navarro J, Noguera I, Medina P. World J Gastroenterol; 2016 Dec 28; 22(48):10545-10556. PubMed ID: 28082806 [Abstract] [Full Text] [Related]
34. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P. Circ Res; 2002 Apr 19; 90(7):764-9. PubMed ID: 11964368 [Abstract] [Full Text] [Related]
36. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. Pope AJ, Karrupiah K, Kearns PN, Xia Y, Cardounel AJ. J Biol Chem; 2009 Dec 18; 284(51):35338-47. PubMed ID: 19820234 [Abstract] [Full Text] [Related]
37. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy. Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S. Nephrol Dial Transplant; 2009 Apr 18; 24(4):1162-9. PubMed ID: 19015171 [Abstract] [Full Text] [Related]
38. Involvement of increased endogenous asymmetric dimethylarginine in the hepatic endoplasmic reticulum stress of type 2 diabetic rats. Leng YP, Qiu N, Fang WJ, Zhang M, He ZM, Xiong Y. PLoS One; 2014 Apr 18; 9(2):e97125. PubMed ID: 24918756 [Abstract] [Full Text] [Related]
39. Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pope AJ, Karuppiah K, Cardounel AJ. Pharmacol Res; 2009 Dec 18; 60(6):461-5. PubMed ID: 19682581 [Abstract] [Full Text] [Related]
40. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Böger RH. Cardiovasc Res; 2003 Oct 01; 59(4):824-33. PubMed ID: 14553822 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]